The present disclosure describes a system for detecting abnormal blood pressure or blood volume in a user, the system comprising a processing system; a pulse transit time (PTT) detection system for providing a PTT signal indicative of a PTT of the user to the processing system, wherein PTT of the user is used as a surrogate for a blood pressure (BP) of the user; and an electrodermal activity (EDA) detection system for providing an EDA signal indicative of an EDA of the user to the processing system; wherein the processing system processes the PTT signal and the EDA signal to determine an index indicative of an abnormal blood pressure or blood volume of the user.

A patient treatment unit and method analyzes and treats pain in tissues by applying an electrical pulse train to the affected tissue. The impedance of the affected tissue is measured, and the measured impedance is correlated to a level of pain in the patient. The pulse train is further applied in response to the measured impedance to reduce the patient's pain. The patient treatment unit includes a probe stimulus generator that outputs the pulse train. The treatment unit also includes a pair of probes for contacting the patient's body and receiving the pulse train. The pulse has improved shaping based on isolation of high voltage from a low voltage control. The unit further includes a body impedance analysis circuit that senses voltage and current via the probes when the probes are contacting the patient and observe the impedance. A monitor is electrically coupled to the body impedance analysis circuit and provides an indication of the measured impedance indicative of the patient's level of pain in real-time.

A patient treatment unit and method analyzes and treats pain in tissues by applying an electrical pulse train to the affected tissue. The impedance of the affected tissue is measured, and the measured impedance is correlated to a level of pain in the patient. The pulse train is further applied in response to the measured impedance to reduce the patient's pain. The patient treatment unit includes a probe stimulus generator that outputs the pulse train. The treatment unit also includes a pair of probes for contacting the patient's body and receiving the pulse train. The pulse has improved shaping based on isolation of high voltage from a low voltage control. The unit further includes a body impedance analysis circuit that senses voltage and current via the probes when the probes are contacting the patient and observe the impedance. A monitor is electrically coupled to the body impedance analysis circuit and provides an indication of the measured impedance indicative of the patient's level of pain in real-time.

A system for treating and/or monitoring a patient includes a patient physiological parameter monitoring patch and a companion device. The patient physiological parameter monitoring patch including an energy harvesting module, an energy storage module, a sensor module and a communication module. The energy harvesting module harvesting energy from one or more ambient sources, the energy being storable in the energy storage module and usable by one or more components of the patient physiological parameter monitoring patch. The sensor module senses one or more physiological parameters of the patient and the communication module can transmit the sensed data. The companion device can receive the sensed physiological parameters and can send the same to a remote device or store the same.

A system for detecting salt ion concentration, comprising a device further comprising a sensor having a carbon printed electrode on a flexible substrate with adhesive on one side (backside) and the circuit electronics to generate pulse signal stimuli and measure salt concentrations to determine hydration level of a person or a living being, wherein the device is a wearable device. The electrode can be made into different shapes changing the area as necessary, since it is a carbon printed electrode and is flexible.

In general, regardless of using an optical method or an electrical AC resistance impedance method, non-invasive blood glucose measurement has a problem in that variations in the level of glucose contained in blood are too small to be measured as a signal, and thus measurement results are inaccurate due to noises generated during measurement and errors caused by the difficulty in consistent measurement. To solve this problem, the present invention provides a non-invasive blood glucose sensor includes: a measurement-unit body; an impedance electrode sensor provided on an inner bottom surface of the measurement-unit body; a signal-generation and measurement unit configured to measure impedance while scanning frequency by supplying multiple frequencies to the impedance electrode sensor; a blood sensor configured to measure the amount of blood flowing through a body part brought into contact with the impedance electrode sensor; and a status display LED configured to display different colors according to the amount of blood measured using the blood sensor. Owing to this configuration, the present invention has an effect of measuring an accurate blood glucose level in a non-invasive manner.

Systems, methods, and devices are provided for predictive maintenance of machines. An example apparatus includes a vibration sensor configured to sense vibrations of a vibration source and an analog circuit. The analog circuit comprises a plurality of operational amplifiers and a plurality of resistors. The analog circuit is coupled to the vibration sensor and configured to: receive an analog signal from the vibration sensor; and compute an output based on the analog signal, by performing a portion of a trained neural network.

Methods and apparatus for detection of tissue damage in users using a PPE device for an extended period of time are disclosed.

Methods and apparatus for detection of tissue damage in users using a PPE device for an extended period of time are disclosed.

Among other things, one or more techniques and/or systems are provided for providing users with access to a route for travelling. A user, of a client device, may send a request for access to the route to a route planning service. The route may correspond to a starting location and an ending location. The route planning service may query a route database to identify an entry indicating that a restricted access road segment (e.g., a high occupancy vehicle lane, a shoulder lane, a bus lane, etc.) and/or a road segment (e.g., comprising a traffic light alteration capability) exists between the starting location and the ending location. Responsive to successfully authorizing the user for travelling the restricted access road segment and/or the road segment, the route, comprising the restricted access road segment and/or the road segment, may be provided to the client device.